SPONSOR
Eisbach Bio GmbH
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Eisbach Bio GmbH is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Eisbach Bio GmbH
How many clinical trials has Eisbach Bio GmbH sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Eisbach Bio GmbH, of which 1 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Eisbach Bio GmbH research focus on?
Eisbach Bio GmbH clinical trials span Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Eisbach Bio GmbH clinical trial?
To participate in a Eisbach Bio GmbH trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Eisbach Bio GmbH trials with current recruitment status updated daily.
Clinical Trials by Eisbach Bio GmbH
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology